Ginkgo bioworks announces date of fourth quarter and full year 2024 results presentation

Presentation and q&a session scheduled for post-market on tuesday, february 25, 2025 boston , feb. 18, 2025 /prnewswire/ -- ginkgo bioworks holdings, inc. (nyse: dna) ("ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and q&a session reviewing business performance for the fourth quarter and full year ended december 31, 2024, on tuesday, february 25, 2025, beginning at 5:30 p.m. et. the presentation details and webcast link will be available on ginkgo's investor relations website at https://investors.ginkgobioworks.com , and a replay will be made available.
DNA Ratings Summary
DNA Quant Ranking